期刊文献+

硬皮病及其在不同人群中遗传因素的差异 被引量:10

Scleroderma and the differences in genetic factors among different race and ethnic groups
在线阅读 下载PDF
导出
摘要 硬皮病是一种复杂的自身免疫性疾病,其主要特征有微血管受损和组织器官纤维化,根据其发病累及范围不同,主要分为系统性硬皮病和局限性硬皮病两种类型。硬皮病发病症状复杂,发病机制不明,导致治疗效果不甚理想。硬皮病发病有家族聚集现象及种族差异,表明硬皮病具有遗传易感性。近年来许多研究集中于寻找硬皮病发病的遗传因素,并已发现有多种候选基因及通路参与硬皮病的发生与发展过程。然而,不同人群中的研究结果并未得出完全一致的结论,群体遗传结构的差异可能与硬皮病的发生密切相关。 Scleroderma is a complex autoimmune disease that mainly characterized by microvascular alteration and fibrosis of the skin and visceral organs.There are two major subgroups according to the implicative range of scleroderma:localized scleroderma and systemic sclerosis.Scleroderma is a syndrome with various phenotypes.The pathogenesis remains unclear and the therapeutic outcome has been poor so far.Familial clustering and differences in phenotypes among race and ethnic groups suggest that genetic factors contribute to scleroderma.Recently,many studies focused on genetic factors and have identified a lot of genes/pathways that are involved in the pathogenesis.However,in the studies of scleroderma among different races,the reports about the polymorphisms of candidate genes are partly conflicting.Therefore,the genetic factors may be closely related with the etiology of scleroderma.
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2011年第3期257-264,共8页 Fudan University Journal of Medical Sciences
基金 国家自然科学基金面上项目(30971594) 上海市科委"科技创新行动计划"基础研究重点科技项目(10JC1402100)
关键词 硬皮病 发病机制 遗传因素 种族差异 scleroderma pathogenesis genetic factors race difference
  • 相关文献

参考文献81

  • 1Bunn CC,Black CM.Systemic sclerosis:an autoantibody mosaic[J].Clin Exp Immunol,1999,117(2):207-208.
  • 2Tamby MC,Chanseaud Y,Guillevin L,et al.New insights into the pathogenesis of systemic sclerosis[J].Autoimmun Rev,2003,2(3):152-157.
  • 3崔冰,胡卓伟.抗肺纤维化药物治疗研究进展[J].生理科学进展,2008,39(3):233-238. 被引量:21
  • 4Brown KK,Raghu G.Medical treatment for pulmonary fibrosis:current trends,concepts,and prospects[J].Clin Chest Med,2004,25(4):759-772.
  • 5赵凯,屠文震.硬皮病研究进展[J].中华风湿病学杂志,2003,7(6):356-359. 被引量:16
  • 6Maureen M,Lacey JV,Beebe-Dimmer J,et al.Prevalence,incidence,survival,and disease characteristics of systemic sclerosis in a large US population[J].Arth & Rheum,2008,8(48):2 246-2 255.
  • 7Granel B,Chevillard C,Dessein A.Genetic factors predisposing to fibrosis in systemic sclerosis[J].Rev Med Interne,2005,26(4):294-303.
  • 8Geirsson AJ,Steinsson K,Guthmundsson S,et al.Systemic sclerosis in Iceland.A nationwide epidemiological study[J].Ann Rheum Dis,1994,53(8):502-505.
  • 9Allcock RJ,Forrest I,Corris PA,et al.A study of the prevalence of systemic sclerosis in northeast England[J].Rheumatology (Oxford),2004,43(5):596-602.
  • 10Le-Guern V,Mahr A,Mouthon L,et al.Prevalence of systemic sclerosis in a French multi-ethnic county[J].Rheumatology (Oxford),2004,43(9):1129-1137.

二级参考文献113

  • 1陈晓栋,吴信峰,王焱,王强,张国成,叶顺章.结缔组织生长因子在瘢痕疙瘩中表达的研究[J].中华皮肤科杂志,2003,36(7):380-383. 被引量:17
  • 2王德军,杨跃林,夏庆杰,兰亚佳,王绵珍,张晓晴,韩吉平,朱启上,孙敏.肿瘤坏死因子基因多态性与矽肺遗传易感性的研究[J].四川大学学报(医学版),2005,36(5):679-682. 被引量:10
  • 3徐礼文,吴斐华,刘保林,蒋洁云.中药治疗肺纤维化的实验研究进展[J].中南药学,2006,4(2):132-135. 被引量:4
  • 4Flavahan NA, Flavahan S, Liu Q, et al. Increased alpha 2-adrenergic constriction of isolated arterioles in diffuse scleroderma[J]. Arthritis Rheum, 2000, 43(8): 1886-1890.
  • 5Stenmark KR, Mecham RP. Cellular and molecular mechanisms of pulmonary vascular remodeling[J]. Annu Rev Physiol, 1997,59: 89-144.
  • 6Thompson AE, Shea B, Welch V, et al. Calcium-channel blockers for Raynaud's phenomenon in systemic sclerosis[J]. Arthritis Rheum, 2001, 44(8): 1841-1847.
  • 7Fishman AP. Pulmonary hypertension--beyond vasodilator therapy[J]. N Engl J Med, 1998, 338(5): 321-322.
  • 8Kahaleh MB, Matucci C, Fan P-S. Modulation of endothelial gene expression in scleroderma by long-term epoprostenol infusion [J].Arthritis Rheum, 1999, 42(Supple): S208.
  • 9Scorza R, Caronni M, Mascagni B, et al. Effects of long-term cyclic iloprost therapy in systemic sclerosis with Raynaud's phenomenon. A randomized, controlled study [J]. Clin Exp Rheumatol, 2001, 19(5): 503-508.
  • 10Black CM, Halkier-Sorensen L, Belch JJ, et al. Oral iloprost in Raynaud's phenomenon secondary to systemic sclerosis: a multicentre, placebo-controlled, dose-comparison study [J]. Br J Rheumatol, 1998, 37(9): 952-960.

共引文献71

同被引文献139

引证文献10

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部